References
- Clark MA, Fisher C, Judson I, Thomas JM. Soft-tissue sarcomas in adults. N Engl J Med 2005; 353: 701-11. doi: 10.1056/NEJMra041866
- Demetri GD, Antonia S, Benjamin RS, Bui MM, Casper ES, Conrad EU, et al. Soft tissue sarcoma. J Natl Compr Canc Netw 2010; 8: 630-74. doi: 10.6004/jnccn.2010.0049
- Cormier JN, Pollock RE. Soft tissue sarcomas. CA Cancer J Clin 2004; 54: 94109. doi: 10.3322/canjclin.54.2.94
- Patel SR. Radiation-induced sarcoma. Curr Treat Options Oncol 2000; 1: 25861. doi: 10.1007/s11864-000-0037-6
- Brady MS, Gaynor JJ, Brennan MF. Radiation-associated sarcoma of bone and soft tissue. Arch Surg 1992; 127: 1379-85. doi: 10.1001/archsurg.1992.01420120013002
- Arya S, Nagarkatti DG, Dudhat SB, Nadkarni KS, Joshi MS, Shinde SR. Soft tissue sarcomas: ultrasonographic evaluation of local recurrences. Clin Radiol 2000; 55: 193-7. doi: 10.1053/crad.1999.0343
- Patel DB, Matcuk Jr GR. Imaging of soft tissue sarcomas. Chin Clin Oncol 2018; 7: 35. doi: 10.21037/cco.2018.07.06
- Ilaslan H, Schils J, Nageotte W, Lietman SA, Sundaram M. Clinical presentation and imaging of bone and soft-tissue sarcomas. Cleve Clin J Med 2010; 77(Suppl 1): S2-7. doi: 10.3949/ccjm.77.s1.01
- Wu JS, Hochman MG. Soft-tissue tumors and tumorlike lesions: a systematic imaging approach. Radiology 2009; 253: 297-316. doi: 10.1148/radiol.2532081199
- Guillou L, Coindre J-M, Bonichon F, Nguyen BB, Terrier P, Collin F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997; 15: 350-62. doi: 10.1200/JCO.1997.15.1.350
- Verweij J, Baker LH. Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular abberations. Eur J Cancer 2010; 46: 863-8. doi: 10.1016/j.ejca.2010.01.016
- Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma 2010; 2010: 506182. doi: 10.1155/2010/506182
- Italiano A, Le Cesne A, Mendiboure J, Blay JY, Piperno-Neumann S, Chevreau C, et al. Prognostic factors and impact of adjuvant treatments on local and metastatic relapse of soft-tissue sarcoma patients in the competing risks setting. Cancer 2014; 120: 3361-9. doi: 10.1002/cncr.28885
- Sedaghat S, Schmitz F, Sedaghat M, Nicolas V. Appearance of recurrent dermatofibrosarcoma protuberans in postoperative MRI follow-up. J Plast Reconstr Aesthet Surg 2020; 73: 1960-65. doi: 10.1016/j.bjps.2020.08.089
- Sedaghat S, Schmitz F, Krieger A, Sedaghat M, Reichardt B. Appearance of recurrent adult fibrosarcoma of the soft tissue and loco-regional post-treatment changes on MRI follow-up. Eur J Plast Surg 2020. doi: 10.1007/s00238-020-01669-1
- Brennan MF, Alektiar KM, Maki RG. Sarcomas of the soft tissue and bone. Section 1: Soft tissue sarcoma. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 6th edition. Philadelphia: Lippincott, Williams & Wilkins. p. 1841-91.
- Weiss SW, Goldblum JR, Folpe AL. Enzinger and Weiss’s soft tissue tumors. 5th edition. Philadelphia PA: Elsevier Health Sciences; 2007.
- Wang X, Jacobs MA, Fayad L. Therapeutic response in musculoskeletal soft tissue sarcomas: evaluation by MRI. NMR Biomed 2011; 24: 750-63. doi: 10.1002/nbm.1731
- Coindre J-M. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 2006; 130: 1448-53. doi: 10.1043/1543-2165(2006)130[1448:GOS TSR]2.0.CO;2
- Zhao F, Ahlawat S, Farahani SJ, Weber KL, Montgomery EA, Carrino JA, Fayad LM. Can MR imaging be used to predict tumor grade in soft-tissue sarcoma? Radiology 2014; 272: 192-201. doi: 10.1148/radiol.14131871
- Lietman SA. Soft-tissue sarcomas: overview of management, with a focus on surgical treatment considerations. Cleve Clin J Med 2010; 77: S13. doi: 10.3949/ccjm.77.s1.03
- Welker JA, Henshaw RM, Jelinek J, Shmookler BM, Malawer MM. The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses: outcomes analysis of 155 patients at a sarcoma referral center. Cancer 2000; 89: 2677-86. doi: 10.1002/1097-0142(20001215)89:12<;2677::aid-cncr22>3.0.co;2-l
- Yang J, Frassica FJ, Fayad L, Clark DP, Weber KL. Analysis of nondiagnostic results after image-guided needle biopsies of musculoskeletal lesions. Clin Orthop Relat Res 2010; 468: 3103-11. doi: 10.1007/s11999-010-1337-1
- Engellau J, Bendahl P-O, Persson A, Domanski HA, Åkerman M, Gustafson P, et al. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays. Hum Pathol 2005; 36: 994-1002. doi: 10.1016/j.humpath.2005.07.008
- Brisse HJ, Orbach D, Klijanienko J. Soft tissue tumours: imaging strategy. Pediatr Radiol 2010; 40: 1019-28. doi: 10.1007/s00247-010-1592-z
- Liang C, Mao H, Tan J, Ji Y, Sun F, Dou W, et al. Synovial sarcoma: Magnetic resonance and computed tomography imaging features and differential diagnostic considerations. Oncol Lett 2015; 9: 661-6. doi: 10.3892/ol.2014.2774
- am de Schepper, Beuckeleer L de, Vandevenne J, Somville J. Magnetic resonance imaging of soft tissue tumors. European radiology 2000; 10: 213-23. doi: 10.1007/s003300050037
- Liu Q-Y, Li H-G, Chen J-Y, Liang B-L. Correlation of MRI features to histopathologic grade of soft tissue sarcoma. Chin J Cancer 2008; 27: 856-60.
- McDonald JS, Hunt CH, Kolbe AB, Schmitz JJ, Hartman RP, Maddox DE, et al. Acute adverse events following gadolinium-based contrast agent administration: a single-center retrospective study of 281 945 injections. Radiology 2019; 292: 620-7. doi: 10.1148/radiol.2019182834
- Am De S, Ramon FA, Degryse HR. Statistical analysis of MRI parameters predicting malignancy in 141 soft tissue masses. Rofo 1992; 156: 587-91. doi: 10.1055/s-2008-1032948
- Tung GA, Davis LM. The role of magnetic resonance imaging in the evaluation of the soft tissue mass. Crit Rev Diagn Imaging 1993; 34: 239.